Description
Asterand plc is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. Their mission is to provide human tissues and services to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.
Share Price
Recent Asterand news
- 01/03/2010 Asterand widens service offering with UK Good Laboratory Practice membership
- 18/02/2010 Asterand completes BioSeek acquisition marking first step in ‘buy-and-build’ strategy
- 09/02/2010 Daniel Stewart still sees 50% upside for Asterand shares, reiterates 'buy'
- 04/02/2010 Asterand posts documentation on proposed BioSeek acquisition to shareholders
- 15/01/2010 Asterand confident in strong growth prospects as BioSeek acquisition progresses well
Presentations & Company Media
No Documents available.
Related Research & Media
Company Statement:
Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, we are uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From our offices in Royston (United Kingdom) and Detroit, Michigan we have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.
Serving a Critical Need
Pharmaceutical research is at a critical crossroads. Despite a dramatic increase in R&D budgets, the number of new drug applications is falling because the failure rate in clinical trials remains high. Researchers have always known that animal models provide only a partial guide to drug response in humans. Thus, scientists are becoming increasingly reliant upon human tissue-based models to bridge this knowledge gap and improve decision making during the development of medicines for man. (Read More)
Current Operations:
Asterand is a leading global supplier of human tissues and biofluids with accompanying clinical information for research purposes.
Extensive human tissue and biofluid repository
Asterand's XpressBANKTM biobank contains several hundred thousand samples from a broad range of anatomic sites, diseases and with diverse ethnic representation. All of our biospecimens are obtained using stringent standard operating procedures and ethical protocols to provide assurance to the researcher that the materials will meet their scientific needs. (Read More)
Asterand's standard collection protocol:
-Frozen & Fixed Tissues
-RNA/DNA
-Biofluids
-Cell Lines
-Tissue Microarrays
-Human Primary Cells
-Custom Procurement
-XpressWayTM Profiles
-CustomMappingTM
-In situ Hybridization
-Immunohistochemistry
-Autoradiography
-Biochemical Pharmacology
-ADMET
Management
Board of Directors
Jack Davis - Chairman
Martyn Coombs - Chief Executive Officer
John Stchur - Chief Financial Officer
Dr. Peter Coggins - Non-Executive Director
Jonathan Fleming - Non-Executive Director
Jill L. Force - Non-Executive Director
Ian Ratcliffe - Non-Executive Director
Robert Salisbury - Non-Executive Director
For more information on Asterand's Directors click here
For information on Asterand's Senior Management click here
Major Shareholders
For investor information click here
Contact Information
USA
Asterand, plc.
TechOne Suite 501
440 Burroughs
Detroit, MI 48202-3420
United States
Tel. + 1 (313) 263-0960
(US Toll Free) 1.866.3TISSUE
Fax: +1 (313) 263.0961
Europe
Asterand, plc.
2 Orchard Road
Royston, Herts
SG8 5HD
United Kingdom
Tel. +44 (0) 1763 211600
Fax. +44 (0) 1763 211555
Japan
Eolas Biosciences Co. Ltd.
134-5-1-918 Shinsaku,
Matsudo-shi
Chiba-ken 271-0052
Japan
Tel: +81-47-308-2204
Fax: +81-47-308-2104
Corporate Information
Registrar
Capita IRG plc,
The Registry,
34 Beckenham Road,
Kent
BR3 4T
Investors interested in Asterand recently viewed:
- Access Pharmaceuticals (OTCBB: .ACCP)
- Alliance Pharma plc (AIM: APH)
- Amphion Innovations (LON: AMP)
- Biocompatibles (LSE: BII)
- BioNeutral Group (OTCBB: .BONU)
- Bionomics (ASX: .BNO)
- Circadian Technologies Limited (ASX: .CIR)
- CogState (ASX: .CGS)
- Eco Animal Health Group Plc (AIM: EAH)
- Epistem (AIM: EHP)
- ImmuPharma PLC (AIM: IMM)
- Lipoxen Plc (AIM: LPX)
- Medical Australia Limited (ASX: MLA)
- Oxford Nutrascience (AIM: ONG)
- Renovo Group Plc (LSE: RNVO)
- Rexahn Pharmaceuticals (AMEX: RNN)
- Starpharma (ASX: .SPL)
- Stirling Products Limited (ASX: .STI)
